Survival-factor-induced phosphorylation of Bad results in its dissociation from Bcl-x(L) but not Bcl-2

I Hirai1, H G Wang

  • 1Drug Discovery Program, H. Lee Moffitt Cancer Center and Research Institute, Department of Interdisciplinary Oncology, University of South Florida College of Medicine, 12902 Magnolia Drive, Tampa FL 33612, USA.

The Biochemical Journal
|October 5, 2001
PubMed

Insights

Interleukin-3 (IL-3) stimulation causes phosphorylation of the pro-apoptotic protein Bad, moving it to the cytoplasm in cells with Bcl-x(L) but not Bcl-2. This phosphorylation is key to Bcl-x(L)

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Apoptosis Research

Background:

  • The Bcl-2 protein family regulates apoptosis, with anti-apoptotic members like Bcl-2 and Bcl-x(L) inhibiting cell death.
  • The pro-apoptotic protein Bad heterodimerizes with Bcl-2 and Bcl-x(L), neutralizing their function and promoting apoptosis.
  • Interleukin-3 (IL-3) is a growth factor that promotes cell survival, particularly in hematopoietic cells.

Purpose of the Study:

  • To investigate the differential effects of Bcl-2 and Bcl-x(L) on the regulation of the pro-apoptotic protein Bad.
  • To elucidate the role of Bad phosphorylation and subcellular localization in mediating the cytoprotective effects of growth factors like IL-3.
  • To determine how the interaction between Bad and Bcl-x(L) versus Bcl-2 is modulated by IL-3 stimulation.

Main Methods:

  • Cell culture experiments using FL5.12 and 293T cell lines.
  • Overexpression of Bad, Bcl-2, Bcl-x(L), and chimeric proteins.
  • Analysis of Bad phosphorylation status using Western blotting.
  • Assessment of Bad subcellular localization via cell fractionation and Western blotting.
  • Induction of apoptosis via IL-3 deprivation.

Main Results:

  • IL-3 stimulation induced Bad phosphorylation at Ser-112, leading to its translocation from mitochondria to the cytoplasm in Bcl-x(L)-expressing cells.
  • Bad overexpression sensitized Bcl-x(L)-expressing cells to IL-3 deprivation-induced apoptosis, while having no effect on Bcl-2-expressing cells.
  • Bcl-2 expression prevented Bad phosphorylation at Ser-136 and Ser-155, sequestering Bad in mitochondrial membranes, unlike Bcl-x(L).
  • Chimeric proteins revealed that the N-terminal region of Bcl-x(L) is crucial for mediating IL-3-induced Bad phosphorylation and cytosolic localization.

Conclusions:

  • Growth factor-mediated phosphorylation of Bad is a critical mechanism contributing to the cytoprotective function of Bcl-x(L).
  • Bcl-2 sequesters Bad in the mitochondria, preventing its phosphorylation and subsequent pro-apoptotic signaling, independent of IL-3.
  • The differential regulation of Bad by Bcl-x(L) and Bcl-2 highlights distinct pathways controlling cell survival and apoptosis in response to growth factor signaling.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...